We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current WINT market cap is 3.28M. The company's latest EPS is USD -2.2571 and P/E is -0.16.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.69M | -4.96M | -4.41M | -11.45M | -4.74M |
| Net Income | -4.43M | -5.15M | 10.22M | -12.02M | -3.75M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 198k | 0 | 0 | 0 | 0 |
| Operating Income | -24.89M | -30.32M | -77.28M | -41.33M | -20.6M |
| Net Income | -27.48M | -32.57M | -67.64M | -39.21M | -20.29M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.06M | 32.41M | 30.1M | 28.71M | 30.45M |
| Total Liabilities | 28.57M | 29.02M | 14.68M | 18.26M | 23.9M |
| Total Equity | 7.48M | 3.39M | 15.42M | 3.49M | 4.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 118.98M | 112.89M | 74.79M | 37.95M | 32.41M |
| Total Liabilities | 44.04M | 43.33M | 32.91M | 27.94M | 29.02M |
| Total Equity | 74.94M | 69.55M | 41.88M | 10.01M | 3.39M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.87M | -13.44M | -2.95M | -5.27M | -11.72M |
| Investing | -15k | -15k | N/A | -12k | -12k |
| Financing | 11.07M | 11.6M | 1.03M | 2.63M | 9.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -24.66M | -25.32M | -23.66M | -19.45M | -13.44M |
| Investing | 13.8M | -291k | -279k | 197k | -15k |
| Financing | 21.77M | 19.96M | 29.36M | 3.08M | 11.6M |
| Market Cap | 3.28M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.77 |
| Price to Book Ratio | 0.98 |
| Dividend Yield | - |
| Shares Outstanding | 8.99M |
| Average Volume (1 week) | 523.89k |
| Average Volume (1 Month) | 1.17M |
| 52 Week Change | -97.25% |
| 52 Week High | 14.7487 |
| 52 Week Low | 0.33 |
| Spread (Intraday) | 0.01 (3.53%) |
| Company Name | Windtree Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.windtreetx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
